Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 1997

View Archived Issues

Company profile: Axiom Biotechnologies

Company profile: Exponential Biotherapies

Company profile: Matrix Pharmaceutical

Novel antiplatelet agent from Cypress Bioscience

Selective 5-HT1D receptor agonist active in two migraine models

Exocell presents new small-molecule antiglycation agent

Guilford's neuroimmunophilin ligand program

Prostaglandins in early development at Allergan for glaucoma

Icos PDE V inhibitor in phase I trials

Guilford presents prototype presynaptic glutamate blocker

PARS inhibitors under development by Guilford for stroke

Name change for Sheffield approved by shareholders

CCK-B antagonist is not effective in anxiety disorders

Etifoxine compared to buspirone for adjustment disorder with anxiety

Low serum cholesterol levels increase risk of suicide in certain psychiatric disorders

Triangle Pharmaceuticals to acquire Avid Corporation

CRF modulator introduced in Italy

Citicoline improves cognitive impairment in animals and elderly subjects

Cholinesterase inhibition with metrifonate studied in rats

SM-13496 preferentially affects mesocortical dopaminergic system

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...